Navigation Links
Intercell AG Announces Q3 2010 Results and Updates on R&D Progress and Management
Date:11/9/2010

vaccine being produced for the U.S. military. U.S. military sales in 2010 depend on further use of residual product stock of JE-Vax®. A significant increase in sales is possible for 2011, when leftover inventory of JE-Vax is expected to be exhausted or abandoned.

The Department of Health, Government of the Hong Kong Special Administrative Regions has approved Intercell's vaccine to prevent Japanese Encephalitis. The licensure process has been initiated for additional territories, and further recommendations are expected also for other key countries in Europe. These recommendations are essential to continue advancing product awareness and market growth.

The pediatric Phase III studies for IXIARO/JESPECT for use in children travelling to endemic areas are progressing according to plan, with data expected in 2012. These studies are the basis for a label extension to make the existing vaccine available for travelling children.

Based on Intercell's technology a novel JE vaccine candidate is also being developed for the endemic markets, where the WHO recommends that Japanese Encephalitis vaccination be integrated into national immunization programs. Clinical development in endemic areas is progressing, with a pivotal Phase III trial in children scheduled to start by the end of 2010 / early 2011 sponsored and managed by Intercell's partner, Biological E., in India.

Leading R&D portfolio in hospital infectionsA Phase II clinical trial involving IC43, the vaccine candidate against infections with the bacterium Pseudomonas aeruginosa, met primary immunogenicity and safety endpoints; a statistically significant reduction in mortality compared to placebo was observed for the non-adjuvanted vaccine group. If confirmed by pivotal clinical trials, this could make IC43 an important vaccine for ICU patients who are subject to a particularly high mortality risk associated with hospital-acquired infections. The vaccine generated a good immune r
'/>"/>

SOURCE Intercell AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intercell Reports Positive Results From Its Phase II Pseudomonas Aeruginosa Investigational Vaccine Study for Certain Hospital-Acquired Infections
2. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
3. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
4. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
5. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
6. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
7. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
8. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
9. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
10. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
11. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)...  Corporate libraries are constantly being faced with a ... and how to cope with flat or shrinking budgets. ... medical device industries are increasingly finding it challenging to ... provide. According to recent research by ... of change that leading corporate libraries are being faced ...
(Date:7/25/2014)... Calif. , July 25, 2014  Depomed, Inc. ... will release second quarter fiscal year 2014 financial results ... Company will host a conference call beginning at 4:30 ... Participants can access the call by dialing 877-317-6789 ( ... conference call will also be available via a live ...
(Date:7/25/2014)... Calif. , July 25, 2014 /PRNewswire-iReach/ -- ... Nieto as the new Vice President of Business ... over 30 years in a number of different business ... the industry. These positions were primarily related to business ... over the past 30 years makes him a key ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2
... Misonix, Inc. (NASDAQ: MSON ), ... markets innovative therapeutic ultrasonic products worldwide for wound ... and other surgical and medical applications, has entered ... Osteotrauma Ltda., based in Concepcion, Chile. Osteotrauma will ...
... 1, 2011 /PRNewswire-USNewswire/ – CoMeD – On ... Programme (UNEP) distributed a revised text for ... mercury-free drugs were gratified to see pharmaceuticals listed in ... treaty. The Coalition for Mercury-free Drugs ...
Cached Medicine Technology:Misonix Announces New Distribution Agreement for Chile 2Misonix Announces New Distribution Agreement for Chile 3Global Mercury Treaty May Include Ban on Mercury in Medicine 2Global Mercury Treaty May Include Ban on Mercury in Medicine 3
(Date:7/28/2014)... new study of the European project SOPHIE has ... policies and gender inequalities in health in Europe. ... policies (central and southern Europe) and countries with ... self-perceived health, i.e. women reported poorer health than ... Europe countries, where women present a 27% higher ...
(Date:7/28/2014)... Termed by the Michigan Osteopathic Association ... fatal overdoses than heroin and cocaine combined, and takes ... are particularly vulnerable to succumbing to prescription overdose are ... in this age group taking at least seven different ... reawakened in the White House in the midst of ...
(Date:7/28/2014)... Karen Pallarito HealthDay ... U.S. taxpayers who go without health insurance this year will ... for a family of five, the Internal Revenue Service says. ... on the federal tax penalties that some Americans will owe ... cap is based on the monthly national average premium for ...
(Date:7/28/2014)... PA (PRWEB) July 28, 2014 "We ... kept shutting," said one of two inventors from Jamestown, ... the lids open so that we could pour medications ... the CONKLIN'S STAY OPEN to keep the lids open ... lids from closing until all compartments have been filled. ...
(Date:7/28/2014)... Community Health Center of Snohomish County (CHC), ... services, has released an article designed to educate patients ... Founded in 1983, the health center has a strong ... that face barriers to obtaining high quality yet affordable ... the CHC, click here: http://www.chcsno.org/locations.ashx?p=1099 , The ...
Breaking Medicine News(10 mins):Health News:Gender inequalities in health: A matter of policies 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 2Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 3Health News:Rx Drug Abuse Labeled Silent Killer: Claims Nearly 17,000 American Lives a Year; Novus Medical Detox Solution Involves Education and Governmental Support 4Health News:IRS Caps Fines on Uninsured Americans at $12K for Family of 5 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 3
... (AMD) is the leading cause of severe visual loss ... common genetic variants which together predict a person,s increased ... without the disease also have these variants. Now, for ... show a specific rare mutation called CFH R1210C that ...
... Chapel Hill, NC In a study published today ... of scientists including UNC biologist Jason Lieb, PhD, present ... can survive with only one copy of the X ... topic in science and provides biologists with more information ...
... EAE President Doctor Luigi Badano, FESC, from the University ... we need to acquire information from all the different ... the ESC, the EAE,s philosophy is that we want ... oriented, so that we,re using the most appropriate technology ...
... Imagine having skin so supple you could stretch it out ... - repeatedly - yet it would always snap back completely ... never need Botox. That enviable elasticity is one of ... sensor that is the latest sensor developed by Stanford,s Zhenan ...
... 23 (HealthDay News) -- Gaining a significant amount of ... risk of developing endometrial cancer, a new study suggests. ... circulating estrogen in postmenopausal women, and estrogen promotes the ... of laboratory services at the National Home Office of ...
... Fla. October 24, 2011 A new analysis of recent eye ... to reduced rates of nearsightedness, also known as myopia, in ... the United States and many other countries than it was ... percent of the population is nearsighted. The analysis suggests that ...
Cached Medicine News:Health News:Researchers ID genetic mutation associated with high risk of age-related macular degeneration 2Health News:Study confirms males and females have at least 1 thing in common: Upregulating X 2Health News:Congress alert: EUROECHO and Other Imaging Modalities: New patient emphasis 2Health News:Congress alert: EUROECHO and Other Imaging Modalities: New patient emphasis 3Health News:Stanford researchers build transparent, super-stretchy skin-like sensor 2Health News:Stanford researchers build transparent, super-stretchy skin-like sensor 3Health News:Weight Gain Might Raise Endometrial Cancer Risk 2Health News:More time outdoors may reduce kids' risk for nearsightedness 2
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
Medicine Products: